Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.60
Bid: 3.68
Ask: 3.94
Change: 0.21 (5.83%)
Spread: 0.26 (7.065%)
Open: 3.60
High: 3.60
Low: 3.60
Prev. Close: 3.60
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PHC Expands Distribution Agreement with Sym-Agro

2 Dec 2015 07:00

RNS Number : 6534H
Plant Health Care PLC
02 December 2015
 

Plant Health Care Expands Distribution Agreement with Sym-Agro, Inc.

 

Raleigh, NC, December 2, 2015. Plant Health Care (AIM: PHC.L), a leading provider of novel biological products to global agriculture markets, today announced that it has signed a new distribution agreement with Sym-Agro Inc. which expands the relationship between the two companies.

 

Under the expanded agreement, Sym-Agro will distribute Employ®, a product based on Plant Health Care's proprietary Harpin αβ protein technology for foliar application, and Myconate®, a mycorrhizal stimulant for plant root growth, across more territories in the Western U.S. agricultural markets. Product usage will also target a wider array of specialty crops. Commercial terms were not disclosed.

 

"Sym-Agro has been a valued partner since 2011 and we are enthusiastic about the investments they have made in field trials, personnel and market development to power this expansion," said Paul Schmidt, CEO of Plant Health Care. "We see continued growth in the specialty markets for these products and anticipate significant volume growth in our business with Sym-Agro."

 

"We're excited about the opportunity to broaden our relationship with Plant Health Care," added Peter Bierma President, Sym-Agro. "Plant Health Care products are a very important part of the Sym-Agro offering to growers. The improvement in yield and quality that we have seen over the past four years has generated strong demand for these products and we look forward to continued growth."

 

- ENDS-

 

 

About Plant Health Care plc: Plant Health Care plc ("Plant Health Care") is a leading provider of novel, patent-protected biological products to global agriculture markets. The Company's ordinary shares have been quoted on the AIM Market of the London Stock Exchange since July 2004 (ticker symbol/mnemonic: PHC.L). The Company offers products to improve the health, vigor and yield of major field crops as well as specialty crops such as fruits and vegetables. PHC's innovative line of proprietary products provides economic and environmental benefits for customers, and capitalizes upon long-term trends towards natural systems and biological solutions to promote plant health and higher yields. Plant Health Care has global reach through operating subsidiaries and supply agreements with major industry partners.

 

About Sym-Agro, Inc: Headquartered in Visalia, California Sym-Agro's focus is to represent, develop, and acquire high quality products to anticipate the evolving markets for solutions to grower needs. The company offers a growing portfolio of unique organic and conventional products and novel formulations. This unique strategy, in combination with an experienced management team, provides solutions and value for our customers. Further information is available at: http://www.sym-agro.com

 

 

 

Further information is available at: www.planthealthcare.comor please contact:

 

Plant Health Care plc

Paul Schmidt, Chief Executive Officer

Tel: +1-919-926-1600 (x100)

Jeff Hovey, Chief Financial Officer

Tel: +1-919-926-1600 (x101)

Liberum

Clayton Bush / Steven Tredget

 

Tel: +44 (0) 20 3100 2227

LHA

Ed McGregor / Jody Burfening

Tel: +1-212-838-3777

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRKFLFBELFEFBE
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.